Onconetix, Inc. — Director's Dealing 2022

Feb 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-23

Reporting Person: Cincinnati Cornerstone Investors BWV I, LLC (10% Owner)
Reporting Person: Cincinnati Cornerstone Capital LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-23	Common Stock	C	3611201	—	Acquired	3611201	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-23	Series Seed Preferred Stock	$1.5225	C	735632	Disposed		Common Stock (3611201)	Direct

Footnotes

F1: The Series Seed Preferred Stock and all related accrued and unpaid dividends automatically converted into Common Stock, as previously agreed, upon the closing of the initial public offering of the Issuer. The Series Seed Preferred Stock was convertible at any time and had no expiration date.

F2: Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein.